Avalyn Pharma Inc. Common Stock (AVLN) is a publicly traded the market company. As of June 3, 2026, AVLN trades at $26.45 with a market cap of $1.18B and a P/E ratio of 0.00. AVLN moved +2.85% today. Year to date, AVLN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $25.05 to $32.23. Analyst consensus is strong buy with an average price target of $52.00. Rallies surfaces AVLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Avalyn Pharma Inc. Common Stock (AVLN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AVLN moved +2.85% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $26.45 |
| Market Cap | $1.18B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.23 |
| 52-Week Low | $25.05 |
| Volume | 292 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover AVLN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.00.